pharmaceutical risk and response seminar...• half life • memory loss • withdrawal 17...

28
1 Pharmaceutical Risk and Response Seminar Keith Bhebhe Penington Institute

Upload: others

Post on 09-Aug-2020

8 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

1

Pharmaceutical Risk and Response Seminar

Keith Bhebhe Penington Institute

Page 2: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

2

Commonly used pharmaceutical drugs

Problematic use of prescription and over-the-counter medicines

Opioid use including pharmaceutical drugs, heroin and illicit synthetic opioids

Overdose risk factors

Treatment options

Recognising overdose (signs of overdose of different drugs including alcohol)

Opioid overdose prevention and response including naloxone

Overview

Page 3: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

3

Commonly misused prescribed medications

Opioids – oxycodone, morphine, methadone, fentanyl, tramadol, codeine

Benzodiazepams – diazepam (valium), temazepam, alprazolam (xanax)

Antipsychotics – seroquel (quetiapine)

Hypnotics – zopiclone, zolpidem and zaleplon

Just because it’s prescribed, it’s not always safe

Page 4: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

4

Accidental drug related deaths, Vic

Page 5: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

5

Fatal overdoses: A coroner`s perspective 2015

www.coronerscourt.vic.gov.au March 2015

Page 6: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

6

Heroin and pharmaceutical opioid overdose deaths

Roxburgh, et al (2017) Trends in heroin and pharmaceutical opioid overdose deaths in Australia. Drug and Alcohol Dependence. Volume 179, 291-298a, doi.org/10.1016/j.drugalcdep.2017.07.018

Page 7: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

7

Overdose deaths Victoria 2016

0

50

100

150

200

250

300

An

nu

al f

req

uen

cy o

f o

verd

ose

dea

ths

Vic

tori

a 2

00

9- 2

01

6

Page 8: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

8

Who is at risk of prescription opioid harm?

477 Victorians died of drug overdose in 2016

40-49 are the most at-risk age group for drug overdose

Economically disadvantaged

Rural populations

Psychiatric illness

A past history of substance abuse

Page 9: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

9

Half life and duration

Page 10: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

10

Oxycodone

One of the most abused prescription drugs around the world.

Brand names include:

• Proladone

• Endone

• OxyNorm

• OxyContin

• Targin (oxycodone + naloxone)

Page 11: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

11

Fentanyl

Approximately 80 - 100 times more potent than morphine

Management of persistent, moderate to severe chronic pain

For opioid tolerant patients who require continuous, around-the-clock opioid administration for an extended period of time

Page 12: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

12

Fentanyl

New Hampshire State Police Forensic Lab

On the left, a lethal dose of heroin; on the right, a lethal dose of fentanyl

Page 13: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

13

Over the counter medication - Codeine

Mostly widely-used opioid analgesic

Short half life

Recommended short lasting and infrequent pain

Usual single dose is 15-60mg

Can cause constipation, nausea and confusion

Changes to legislation Feb 2018

Page 14: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

14

Physical impact

differencebetween.net

Page 15: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

15

Opioids withdrawal

Drug and Alcohol Clinical Advisory Service (DACAS) SA Health

Page 16: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

16

Benzodiazepines

Considerations: • Drug interaction - overdoses • Half life • Memory loss • Withdrawal

Page 17: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

17

Multi-drug overdoses - Benzodiazepines

Page 18: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

18

Benzodiazepines – alprazolam (Xanax)

Treatment of anxiety and panic disorders

Should be short term use only

Reports of severe withdrawal symptoms

Intense rebound of anxiety

Interaction with SSRIs (delayed clearance)

Page 19: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

19

Associated with an increased risk of: • Amnesia • Sedation, reduced alertness • Ataxia, reduced mobility, falls, fractures • Night wandering • Incontinence • Pseudodementia

Benzodiazepines – elderly

Page 20: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

20

Harm reduction

Avoid injecting above your shoulder

Avoid injecting below your waist

Page 21: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

21

Treatment options and harm reduction strategies

Opioids replacement/substitute/maintenance therapy (ORT/OST/OMT)

Daily dispensing for individuals undergoing ORT/OST

Prescription monitoring programs

Changes to scheduling of medications – codeine

Needle syringe programs

Naltrexone – implant options

Education – to prescribers, frontline staff and patients

Page 22: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

22

Treatment options and harm reduction strategies

Prescription monitoring programs

Prescription drug take back

Improved opioid prescribing education

Improved consumer opioid education

Improved pain management practice

Improved mental health management

Increased accountability, responsible marketing, research and related funding initiatives from pharmaceutical companies

Page 23: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

23

Harm reduction strategies

OxyContin OC versus OP

Page 24: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

24

Harm reduction strategies

medicine-online.org/img/cms/targin.jpg

Page 25: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

25

Treatment options - Non-pharmacology strategies for CNCP

Planned daily walks or exercise

Physiotherapy/hydrotherapy

Counselling (may be available online or via telephone)

Relaxation therapy/mindfulness/yoga

Nutritional change with support from a dietitian

Attending a group pain management program

Social connection

Page 26: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

26

Direct Line 1800 888 236 www.directline.org.au

www.scriptwise.org.au 03 9909 2807

Medication support and recovery services (MSRS) 1800 931 101

Family Drug Helpline 1300 660 068

Healthdirect Australia - Free health advice 24 hours, 7 days a week on 1800 022 222

Disposal Helpline 1800 552 355

Reconnexion: Anxiety, panic, depression, benzodiazepine dependency. www.reconnexion.org.au 1300 273 266 or 03 9809 8200

Australian Pain Society – Facility Directory: www.apsoc.org.au/facility-directory

Confidential and free information, counselling and referral helpline resources

Page 27: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

27

Reference list

Cayoun B, Simmons A and Shires A (2017) Immediate and lasting chronic pain reduction following brief self implemented mindfulness based interoceptive exposure task: A pilot study. Mindfulness. doi 10.1007/s/2671-017-0823x

Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioural therapy for treatment of chronic primary insomnia a randomized controlled trial. JAMA 2001;285:1856-64.

Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioural and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999;281:991-9.

Nielsen S, Bruno R, Lintzeris N, Fischer J, Carruthers S, Stoové M. Pharmaceutical opioid analgesic and heroin dependence: How do treatment-seeking clients differ in Australia? Drug Alcohol Rev 2011;30:291-9

Nielsen S, Bruno R, Degenhardt L, Stoove MA, Fischer JA, Carruthers SJ, et al. The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids. Med J Aust 2013;199:696-9.

Office of National Drug Control Policy (ONDCP). Epidemic: Responding to America's Prescription Drug Abuse Crisis. Washington DC, USA: Executive office of the President of the United States; 2011.

Roxburgh, et al (2017) Trends in heroin and pharmaceutical opioid overdose deaths in Australia. Drug and Alcohol Dependence. Volume 179, 291-298a, doi.org/10.1016/j.drugalcdep.2017.07.018

Tiller JWG. Cognitive behaviour therapy in medical practice. Aust Prescr 2001;24:33-7.

Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Zolpidem use and hip fractures in older people. J Am Geriatr Soc 2001;49:1685-90.

Wilson C, Lack L. Sleeping habits of people living in the Adelaide metropolitan area - a telephone survey. Aust Psychol 1983;18:369-76.

www.nps.org.au/australian-prescriber/articles/the-management-of-insomnia-an-update

www.msrs.org.au

www.tga.gov.au/codeine-info-hub

.

Page 28: Pharmaceutical Risk and Response Seminar...• Half life • Memory loss • Withdrawal 17 Multi-drug overdoses - Benzodiazepines 18 Benzodiazepines – alprazolam (Xanax) Treatment

28

CONTACT DETAILS

Penington Institute

95 Drummond Street

Carlton Vic 3053

E: [email protected]